Manufacturer
Akebia Therapeutics
- Products listed
- 4
- Molecules
- 2
- Therapy areas
- 1
Akebia Therapeutics is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 4 of its products across 2 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Indian manufacturer
- No
- Also listed as
- Akebia Therapeutics, Inc.
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Akebia Therapeutics products through licensed channels, with the documents your regulator needs.
Haematology
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Auryxia 210 mg tabletOral | Tetraferric tricitrate | US FDA | Available on request |
Other products
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Vafseo 150 mg tabletOral | Vadadustat | US FDA | Available on request |
| Vafseo 300 mg tabletOral | Vadadustat | US FDA | Available on request |
| Vafseo 450 mg tabletOral | Vadadustat | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Akebia Therapeutics
Send a request for any of these products. We confirm the licensed source, documents and lead time.